title: CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma.
authors.affiliation: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
authors.forename: Ahmad A
authors.initials: AA
authors.lastname: Tarhini
authors.forename: John M
authors.initials: JM
authors.lastname: Kirkwood
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD; D060908:CTLA-4 Antigen; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007167:Immunotherapy; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab